Double defense: new mRNA vaccine targets two lung viruses in seniors
NCT ID NCT06686654
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new mRNA vaccine designed to protect adults aged 60 and older from two viruses that can cause serious lung infections: human metapneumovirus (hMPV) and respiratory syncytial virus (RSV). About 1,530 participants will receive either the vaccine or a placebo to check safety and immune response. The trial also looks at how well a booster shot works a year after the first vaccination.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN METAPNEUMOVIRUS IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel CNS-Garden Grove- Site Number : 8400017
Garden Grove, California, 92845, United States
-
National Research Institute - Gardena- Site Number : 8400005
Gardena, California, 90247, United States
-
National Research Institute - Huntington Park- Site Number : 8400014
Huntington Park, California, 90255, United States
-
National Research Institute - Panorama City- Site Number : 8400012
Los Angeles, California, 91402, United States
-
Peninsula Research Associates- Site Number : 8400002
Rolling Hills Estates, California, 90274, United States
-
Providence Clinical Research - North Hollywood- Site Number : 8400018
North Hollywood, California, 91606, United States
-
Suncoast Research Associates - Miami - Sunset Drive- Site Number : 8400001
Miami, Florida, 33173, United States
-
Velocity Clinical Research - Austin- Site Number : 8400020
Cedar Park, Texas, 78613, United States
-
Velocity Clinical Research - Denver- Site Number : 8400016
Englewood, Colorado, 80110, United States
-
Velocity Clinical Research - Hallandale Beach- Site Number : 8400022
Hallandale, Florida, 33009, United States
-
Velocity Clinical Research - Hampton- Site Number : 8400026
Hampton, Virginia, 23666, United States
-
Velocity Clinical Research - Kansas City- Site Number : 8400015
Overland Park, Kansas, 66210, United States
-
Velocity Clinical Research - Lincoln - Valley Road- Site Number : 8400023
Lincoln, Nebraska, 68510, United States
-
Velocity Clinical Research - Medford- Site Number : 8400024
Medford, Oregon, 97504, United States
-
Velocity Clinical Research - Meridian- Site Number : 8400003
Meridian, Idaho, 83642, United States
-
Velocity Clinical Research - Omaha- Site Number : 8400006
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research - Rockville- Site Number : 8400011
Rockville, Maryland, 20854, United States
-
Velocity Clinical Research - Salt Lake City- Site Number : 8400010
West Jordan, Utah, 84088, United States
-
Velocity Clinical Research - San Diego- Site Number : 8400008
La Mesa, California, 91942, United States
-
Velocity Clinical Research - Seattle- Site Number : 8400019
Seattle, Washington, 98105, United States
-
Velocity Clinical Research - Springdale- Site Number : 8400004
Cincinnati, Ohio, 45246, United States
-
Velocity Clinical Research - Washington DC- Site Number : 8400007
Washington D.C., District of Columbia, 20016, United States
-
Velocity Clinical Research Los Angeles- Site Number : 8400013
Los Angeles, California, 90017, United States
-
Velocity Clinical Research, Phoenix- Site Number : 8400025
Phoenix, Arizona, 85006, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.